Novartis (NVS)

74.16 -0.85  -1.13%  May 17, 4:59PM
Add to Watchlists Create an Alert

Novartis Revenue Quarterly YoY Growth:

2.11% for March 31, 2013
View Full Chart

Novartis Revenue Quarterly YoY Growth Chart

    Novartis Historical Revenue Quarterly YoY Growth Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 2.11%
    Dec. 31, 2012 0.48%
    Sept. 30, 2012 -6.62%
    June 30, 2012 -3.85%
    March 31, 2012 -2.17%
    Dec. 31, 2011 3.68%
    Sept. 30, 2011 17.27%
    June 30, 2011 26.86%
    March 31, 2011 15.10%
    Dec. 31, 2010 10.03%
    Sept. 30, 2010 13.55%
    June 30, 2010 10.98%
    March 31, 2010 24.48%
    Dec. 31, 2009 27.03%
    Sept. 30, 2009 2.36%
    June 30, 2009 -2.26%
    March 31, 2009 -2.84%
    Dec. 31, 2008 11.32%
    Sept. 30, 2008 12.34%
    June 30, 2008 16.91%
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro

    About Revenue Growth

    Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.

    If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
    Learn More

    Get data for

    NVS Revenue Quarterly YoY Growth Benchmarks

    Companies
    Pfizer -12.37%
    Sanofi -12.14%
    Merck -9.04%

    NVS Revenue Quarterly YoY Growth Rankings

    Overall 65th percentile
    2737 of 8007
    Sector 57th percentile
    294 of 685 in Healthcare
    Industry 68th percentile
    17 of 54 in Drug Manufacturers - Major

    NVS Revenue Quarterly YoY Growth Range, Past 5 Years

    Minimum -6.62% Sep 2012
    Maximum 27.03% Dec 2009
    Average 8.84%